Securities code: Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) stock abbreviation: Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) No.: Lin 2022046 bond Code: 143422 bond abbreviation: 18 Fuyao 01
Bond Code: 155067 bond abbreviation: 18 Fuyao 02
Bond Code: 175708 bond abbreviation: 21 Fuyao 01
Shanghai Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (Group) Co., Ltd
Announcement of profit distribution plan for 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important content tips (the interpretation is the same as the text):
● distribution ratio per share: cash dividend of RMB 0.56 per share (before tax); No capital reserve will be converted into share capital and no bonus shares will be given.
● the profit distribution is based on the total share capital of the equity registered Japanese company specified in the equity distribution implementation announcement, and the specific date will be specified in the equity distribution implementation announcement.
● if the total share capital of the company changes before the equity registration date specified in the equity distribution implementation announcement, it is proposed to maintain the distribution proportion per share unchanged, adjust the total distribution accordingly, and announce the specific adjustment separately.
1、 Contents of profit distribution plan
Audited by Ernst & Young Huaming Certified Public Accountants (special general partnership), the actual profit available for distribution to shareholders of Shanghai Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (Group) Co., Ltd. (hereinafter referred to as “the company”) at the end of 2021 was 1064698498180 yuan.
The profit distribution plan of the company is proposed to be approved at the 6th annual general meeting of the company (2021) and approved by the 6th annual general meeting of the company as follows:
In accordance with the articles of association and other relevant provisions, it is agreed and submitted to the general meeting of shareholders for approval that the company will distribute a cash dividend of RMB 5.60 (before tax) to all shareholders for every 10 shares based on the total share capital of the equity registration Japanese company specified in the equity distribution implementation announcement.
According to the total share capital of 2562898545 shares of the company as of March 22, 2022, the total amount of cash dividends distributed in 2021 accounts for about 30.31% of the net profit attributable to shareholders of Listed Companies in the consolidated statements of the group (i.e. the company and its holding subsidiaries / units, the same below) in 2021.
If the total share capital of the company changes before the equity registration date specified in the announcement on the implementation of equity distribution, it is proposed to maintain the distribution proportion per share unchanged, adjust the total distribution accordingly, and make a separate announcement on the specific adjustment.
The profit distribution plan needs to be submitted to the general meeting of shareholders of the company for deliberation.
2、 Decision making procedures performed by the company
(I) convening, deliberation and voting of the board meeting
The 66th meeting (regular meeting) of the 8th board of directors of the company reviewed and approved the profit distribution plan for 2021 and agreed to submit it to the general meeting of shareholders of the company for deliberation. When voting on this proposal, all directors unanimously agreed.
(II) opinions of independent non-executive directors
The 2021 profit distribution plan comprehensively considers the industry characteristics, development stage, operation and financial status, profitability and medium and long-term development of the group, complies with relevant laws and regulations and the articles of association, and does not damage the interests of shareholders of the company, especially small and medium-sized shareholders, which is conducive to the sustainable and stable development of the group. Agree to the plan and submit it to the general meeting of shareholders for deliberation.
3、 Relevant risk tips
This profit distribution plan combines the group’s development stage, future capital demand and other factors, and will not have a significant impact on the group’s operating cash flow, and will not affect the normal operation and long-term development of the group.
The profit distribution plan can only be implemented after being approved by the general meeting of shareholders of the company. Please pay attention to investment risks.
It is hereby announced.
Board of directors of Shanghai Shanghai Fosun Pharmaceutical (Group) Co.Ltd(600196) (Group) Co., Ltd. March 22, 2002
